Clinical Trial Update: Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva [Phase 2, Phase 3]

View source ↗

Summary

Update on the ANRS 135 Primeva trial assessing prevention of HIV-1 mother-to-child transmission in the pre-partum period without nucleoside RT inhibitors; the P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV Infections | Phase 2, Phase 3 | Status: COMPLETED